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To the Editor: Two recent articles have reported the burden
of vitamin D deficiency in patients with chronic kidney
disease (CKD).1,2 We would like to highlight the increased
risk in patients of SE Asian origin, an ethnic group known to
be at risk of hypovitaminosis D due to diet and lack of
sunlight exposure.3 We have measured circulating vitamin D
and markers of bone metabolism in 113 prevalent stage 3 and
stage 4 patients (60 Caucasians and 53 SE Asians). SE Asians
were younger than Caucasians (68±13 vs 63±13 years,
P¼ 0.025). Seventy-seven of the patients were men, and 30
had diabetes mellitus, which was predictably more prevalent
in SE Asians (40 vs 15%, w2-test P¼ 0.003). Fifty-two patients
had CKD 3 and 61 patients had CKD 4. Calcium, phosphate,
and alkaline phosphatase were not different between groups
(CKD or ethnicity). 25(OH)D3 was not different between
CKD3 and 4 (15.9±9.6 vs 15.3±8.9 ng ml1, P¼NS). SE
Asians had lower 25(OH)D3 than Caucasians (10.3±6.4 vs
20.3±8.7 ng ml1, Po0.001) (Figure 1). 25(OH)D3 was
below the level of detection in nine patients, all SE Asians—
four with CKD 3 and five with CKD 4. No difference was
found in mean parathyroid hormone levels between races. An
increase in parathyroid hormone was observed with worsen-
ing stage of CKD (10±8 vs 15±11 pmol l1 CKD 3 vs CKD
4, P¼ 0.01). A decrease in 25(OH)D3 was associated with an
increase in parathyroid hormone (Pearson’s r¼0.27,
P¼ 0.01). Rising parathyroid hormone predictably correlated
with a decreasing estimated glomerular filtration rate
(Pearson’s r¼0.34, P¼ 0.001). Larger studies are needed
to investigate the benefits of replacement of vitamin D at
physiological doses in CKD patients of different ethnic
groups.
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The letter to the editor from Kosmadakis et al.1 references
our findings of 25-hydroxyvitamin D (25OHD) levels in
the National Health Examination Survey (NHANES III).2
In their subjects, no significant differences in 25OHD
levels between stage III and IV chronic kidney disease
(CKD) were observed, although both levels were consistent
with 25OHD insufficiency.3 These findings are contrary to
what was observed in NHANES III where the major decline
in 25OHD was observed in stage IV CKD.
In response, we would like to point out potential reasons
for these differences in their study compared with NHANES
III which include (1) a small number of subjects with CKD
stage III (52 vs 854), (2) the lack of adjustment of 25OHD
levels with leisure physical activity as an indirect measure-
ment of sunlight exposure, and (3) the high preva-
lence of diabetes. Although no information is provided
regarding urinary protein excretion, it is likely that their
stage III and IV CKD diabetic patients had some degree of
proteinuria. This could explain the lower values of 25OHD
l e t t e r t o t h e e d i t o r http://www.kidney-international.org
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Figure 1 | 25(OH)D3 levels vs ethnicity (Po0.001).
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